Circle Pharma Receives $3,808,348 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f807b898-a530-4972-acdf-406c8bf9096d - Date
9/13/2016 - Company Name
Circle Pharma - Mailing Address
280 Utah Avenue San Francisco, CA 94080 USA - Company Description
We design and develop bioavailable macrocyclic peptide therapeutics against important clinical targets. We do this by applying a computational structure-based design approach that combines physics (conformational modeling), chemistry (innovative molecular components) and biology (protein target structure and function). - Website
http://www.circlepharma.com - Transaction Type
Venture Equity, Debt - Transaction Amount
$3,808,348 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. 4 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
